Page 1 | Search Results | Blood | American Society of Hematology

1-17 of 17

Sort by

Sort Order Select

Journal Articles

MicroRNA profiles of t(14;18)–negative follicular lymphoma support a late germinal center B-cell phenotype

Blood (2011) 118 (20): 5550–5558.

https://doi.org/10.1182/blood-2011-06-361972

Published: 2011

Includes: Supplemental data

Journal Articles

Pathway discovery in mantle cell lymphoma by integrated analysis of high-resolution gene expression and copy number profiling

Blood (2010) 116 (6): 953–961.

https://doi.org/10.1182/blood-2010-01-263806

Published: 2010

Includes: Supplemental data

Journal Articles

Two Cycles of ABVD Followed by Involved Field Radiotherapy with 20 Gray (Gy) Is the New Standard of Care in the Treatment of Patients with Early-Stage Hodgkin Lymphoma: Final Analysis of the Randomized German Hodgkin Study Group (GHSG) HD10. Study Supported by the Deutsche Krebshilfe and in Part by the Competence Network Malignant Lymphoma.

Andreas Engert, MD, Volker Diehl, MD, Emeritus, Annette Pluetschow, Hans T. Eich, Richard Herrmann, MD, Bernd Doerken, Lothar Kanz, MD, Richard Greil, Jana Markova, Michael Fuchs, Peter Borchmann, PD, Dr., Hans Konrad Mueller-Hermelink, Rolf Peter Mueller

Blood (2009) 114 (22): 716.

https://doi.org/10.1182/blood.V114.22.716.716

Published: 2009

Journal Articles

Combined Modality Treatment with Intensified Chemotherapy and Dose-Reduced Involved Field Radiotherapy in Patients with Early Unfavourable Hodgkin Lymphoma (HL): Final Analysis of the German Hodgkin Study Group (GHSG) HD11 Trial.

Peter Borchmann, Volker Diehl, Helen Goergen, Horst Mueller, Rolf Peter Mueller, Hans T. Eich, Hans Konrad Mueller-Hermelink, Richard Herrmann, MD, Jana Markova, Anthony D. Ho, MD, PhD, Wolfgang Hiddemann, Bernd Doerken, Richard Greil, Andreas Engert, MD

Blood (2009) 114 (22): 717.

https://doi.org/10.1182/blood.V114.22.717.717

Published: 2009

Journal Articles

Follicular lymphomas with and without translocation t(14;18) differ in gene expression profiles and genetic alterations

Blood (2009) 114 (4): 826–834.

https://doi.org/10.1182/blood-2009-01-198580

Published: 2009

Includes: Supplemental data

Journal Articles

Eight Cycles of BEACOPP Escalated Compared with 4 Cycles of BEACOPP Escalated Followed by 4 Cycles of BEACOPP Baseline with Our without Radiotherapy in Patients in Advanced Stage Hodgkin Lymphoma (HL): Final Analysis of the Randomised HD12 Trial of the German Hodgkin Study Group (GHSG).

Volker Diehl, Heinz Haverkamp, Rolf Peter Mueller, Hans Theodor Eich, Hans Konrad Mueller-Hermelink, Thomas Cerny, Jana Markova, Anthony Ho, Lothar Kanz, Richard Greil, Wolfgang Hiddemann, Andreas Engert

Blood (2008) 112 (11): 1558.

https://doi.org/10.1182/blood.V112.11.1558.1558

Published: 2008

Journal Articles

Follicular Lymphomas with and without Translocation t(14;18) Differ in Gene Expression Profiles and Genetic Alterations.

Ellen Leich, Itziar Salaverria, Silvia Bea, PhD, Andreas Zettl, MD, Randy D. Gascoyne, MD, Wing-Chung Chan, MD, Rita M. Braziel, MD, Lisa M. Rimsza, MD, Dennis D. Weisenburger, MD, Jan Delabie, MD, Elaine S. Jaffe, MD, Thomas A. Lister, Andrew J. Norton, MD, Louis M. Staudt, MD, PhD, Elena M. Hartmann, MD, Hans-Konrad Mueller-Hermelink, MD, Elias Campo, MD, PhD, German Ott, MD, Andreas Rosenwald, MD

Blood (2007) 110 (11): 360.

https://doi.org/10.1182/blood.V110.11.360.360

Published: 2007

Journal Articles

Different Outcome for Angioimmunoblastic T-Cell Lymphoma (AIL) and Peripheral T-Cell Lymphoma Unspecified (PTCL-U) Following Upfront Autologous Stem Cell Transplantation.

Peter Reimer, MD, Thomas Ruediger, MD, Florian Weissinger, MD, Hans Konrad Mueller-Hermelink, Andreas Engert, Hermann Einsele, Martin Wilhelm

Blood (2006) 108 (11): 5431.

https://doi.org/10.1182/blood.V108.11.5431.5431

Published: 2006

Journal Articles

HD12 Randomised Trial Comparing 8 Dose-Escalated Cycles of BEACOPP with 4 Escalated and 4 Baseline Cycles in Patients with Advanced Stage Hodgkin Lymphoma (HL): An Analysis of the German Hodgkin Lymphoma Study Group (GHSG), University of Cologne, D-50924 Cologne, Germany.

Andreas Engert, Jeremy Franklin, Rolf-Peter Mueller, Hans-Theodor Eich, Axel Gossmann, Hans Konrad Mueller-Hermelink, Thomas Cerny, Jana Markova, Anthony D. Ho, Lothar Kanz, Richard Greil, Wolfgang Hiddemann, Beate Pfistner, Volker Diehl

Blood (2006) 108 (11): 99.

https://doi.org/10.1182/blood.V108.11.99.99

Published: 2006

Journal Articles

Autologous Stem Cell Transplantation as First-Line Therapy in Peripheral T-Cell Lymphomas. A Prospective Multicenter Study.

Peter Reimer, MD, Thomas Ruediger, MD, Tobias Schertlin, MD, Eva Geissinger, MD, Florian Weissinger, MD, Hermann Einsele, Hans Konrad Mueller-Hermelink, Martin Wilhelm

Blood (2005) 106 (11): 2074.

https://doi.org/10.1182/blood.V106.11.2074.2074

Published: 2005

Journal Articles

Genetic Rearrangements of FOXP1 Are Restricted to a Subset of Agressive B Cell Lymphoma with Extranodal Presentation.

Eugenia Haralambieva, MD, Patrick Adam, MD, Irina Eichelbroenner, Joerg Kalla, MD, PhD, Andreas Rosenwald, MD, PhD, Tiemo Katzenberger, MD, Sylvia Hoeller, MD, Alison H. Banham, PhD, Hans Konrad Mueller-Hermelink, MD, PhD, German Ott, MD, PhD

Blood (2005) 106 (11): 2837.

https://doi.org/10.1182/blood.V106.11.2837.2837

Published: 2005

Journal Articles

Combined Modality Treatment of Two or Four Cycles of ABVD Followed by Involved Field Radiotherapy in the Treatment of Patients with Early Stage Hodgkin’s Lymphoma: Update Interim Analysis of the Randomised HD10 Study of the German Hodgkin Study Group (GHSG).

Andreas Engert, Annette Pluetschow, Hans T. Eich, Richard Herrmann, Bernd Doerken, Lothar Kanz, Richard Greil, Jana Markova, Beate Pfistner, Andreas Josting, Konrad Mueller-Hermelink, Ralf P. Mueller, Volker Diehl

Blood (2005) 106 (11): 2673.

https://doi.org/10.1182/blood.V106.11.2673.2673

Published: 2005

Journal Articles

Recent Interim Analysis of the HD11 Trial of the GHSG: Intensification of Chemotherapy and Reduction of Radiation Dose in Early Unfavorable Stage Hodgkin’s Lymphoma.

Volker Diehl, Corinne Brillant, Andreas Engert, Ralf-Peter Mueller, Hans-Theodor Eich, Konrad Mueller-Hermelink, Richard Herrmann, Jana Markova, Anthony Ho, Wolfgang Hiddemann, Bernd Doerken, Richard Greil, Andreas Josting, Beate Pfistner

Blood (2005) 106 (11): 816.

https://doi.org/10.1182/blood.V106.11.816.816

Published: 2005

Journal Articles

The Grey Zone between Burkitt and Diffuse Large B Cell Lymphomas: Impact of Chromosomal Breakponts at Myc and Other Loci.

Eugenia Haralambieva, Evert-jan Boerma, Gustaaf van Imhoff, MD, Stefano Rosati, MD, Ed Schuuring, PhD, Hans-Konrad Mueller-Hermelink, MD PhD, Philip M. Kluin, MD PhD, German Ott, MD PhD

Blood (2004) 104 (11): 2275.

https://doi.org/10.1182/blood.V104.11.2275.2275

Published: 2004

Journal Articles

Chromosomal Imbalances in Germinal Center B-Cell-Like and Activated B-Cell-Like Diffuse Large B-Cell Lymphoma Influence Gene Expression Signatures and Improve Gene Expression-Based Survival Prediction(the First Two Authors Contributed Equally to This Work).

Blood (2004) 104 (11): 415.

https://doi.org/10.1182/blood.V104.11.415.415

Published: 2004

Journal Articles

Autologous Stem Cell Transplantation as First Line Therapy in Peripheral T Cell Lymphomas. Update of a Prospective Multicenter Study.

Peter Reimer, MD, Thomas Ruediger, MD, Tobias Schertlin, Eva Geissinger, MD, Florian Weissinger, MD, Hans Konrad Mueller-Hermelink, Martin Wilhelm

Blood (2004) 104 (11): 904.

https://doi.org/10.1182/blood.V104.11.904.904

Published: 2004

Journal Articles

Tumor cell agglutination and not solely cytokine release as mechanism of adverse reactions during anti-CD20 monoclonal antibody (IDEC-C2B8, rituximab) treatment

Volker Kunzmann, Thomas Ruediger, Michael Hallek, Hans-Konrad Mueller-Hermelink, Martin Wilhelm

Blood (2001) 98 (6): 1991–1992.

https://doi.org/10.1182/blood.V98.6.1991

Published: 2001

NARROW

MicroRNA profiles of t(14;18)–negative follicular lymphoma support a late germinal center B-cell phenotype

Pathway discovery in mantle cell lymphoma by integrated analysis of high-resolution gene expression and copy number profiling

Combined Modality Treatment with Intensified Chemotherapy and Dose-Reduced Involved Field Radiotherapy in Patients with Early Unfavourable Hodgkin Lymphoma (HL): Final Analysis of the German Hodgkin Study Group (GHSG) HD11 Trial.

Follicular lymphomas with and without translocation t(14;18) differ in gene expression profiles and genetic alterations

Eight Cycles of BEACOPP Escalated Compared with 4 Cycles of BEACOPP Escalated Followed by 4 Cycles of BEACOPP Baseline with Our without Radiotherapy in Patients in Advanced Stage Hodgkin Lymphoma (HL): Final Analysis of the Randomised HD12 Trial of the German Hodgkin Study Group (GHSG).

Follicular Lymphomas with and without Translocation t(14;18) Differ in Gene Expression Profiles and Genetic Alterations.

Different Outcome for Angioimmunoblastic T-Cell Lymphoma (AIL) and Peripheral T-Cell Lymphoma Unspecified (PTCL-U) Following Upfront Autologous Stem Cell Transplantation.

HD12 Randomised Trial Comparing 8 Dose-Escalated Cycles of BEACOPP with 4 Escalated and 4 Baseline Cycles in Patients with Advanced Stage Hodgkin Lymphoma (HL): An Analysis of the German Hodgkin Lymphoma Study Group (GHSG), University of Cologne, D-50924 Cologne, Germany.

Autologous Stem Cell Transplantation as First-Line Therapy in Peripheral T-Cell Lymphomas. A Prospective Multicenter Study.

Genetic Rearrangements of FOXP1 Are Restricted to a Subset of Agressive B Cell Lymphoma with Extranodal Presentation.

Combined Modality Treatment of Two or Four Cycles of ABVD Followed by Involved Field Radiotherapy in the Treatment of Patients with Early Stage Hodgkin’s Lymphoma: Update Interim Analysis of the Randomised HD10 Study of the German Hodgkin Study Group (GHSG).

Recent Interim Analysis of the HD11 Trial of the GHSG: Intensification of Chemotherapy and Reduction of Radiation Dose in Early Unfavorable Stage Hodgkin’s Lymphoma.

The Grey Zone between Burkitt and Diffuse Large B Cell Lymphomas: Impact of Chromosomal Breakponts at Myc and Other Loci.

Chromosomal Imbalances in Germinal Center B-Cell-Like and Activated B-Cell-Like Diffuse Large B-Cell Lymphoma Influence Gene Expression Signatures and Improve Gene Expression-Based Survival Prediction(the First Two Authors Contributed Equally to This Work).

Autologous Stem Cell Transplantation as First Line Therapy in Peripheral T Cell Lymphomas. Update of a Prospective Multicenter Study.

Tumor cell agglutination and not solely cytokine release as mechanism of adverse reactions during anti-CD20 monoclonal antibody (IDEC-C2B8, rituximab) treatment

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only